{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:05:41Z","timestamp":1770476741075,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1038\/sj.bjc.6601532","type":"journal-article","created":{"date-parts":[[2004,1,20]],"date-time":"2004-01-20T18:41:36Z","timestamp":1074624096000},"page":"443-448","source":"Crossref","is-referenced-by-count":18,"title":["Detection of HER-2\/neu-positive circulating epithelial cells in prostate cancer patients"],"prefix":"10.1038","volume":"90","author":[{"given":"N","family":"Ady","sequence":"first","affiliation":[]},{"given":"L","family":"Morat","sequence":"additional","affiliation":[]},{"given":"K","family":"Fizazi","sequence":"additional","affiliation":[]},{"given":"J-C","family":"Soria","sequence":"additional","affiliation":[]},{"given":"M-C","family":"Mathieu","sequence":"additional","affiliation":[]},{"given":"D","family":"Prapotnich","sequence":"additional","affiliation":[]},{"given":"L","family":"Sabatier","sequence":"additional","affiliation":[]},{"given":"L","family":"Chauveinc","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2004,1,20]]},"reference":[{"key":"BF6601532_CR1","first-page":"4761","volume":"59","author":"DB Agus","year":"1999","unstructured":"Agus DB, Scher HI, Higgins B, Fox WD, Heller G, Fazzari M, Cordon-Cardo C, Golde DW (1999) Response of prostate cancer to anti-HER-2\/neu antibody in androgen-dependent and \u2013independent human xenograft models. Cancer Res 59: 4761\u20134764","journal-title":"Cancer Res"},{"key":"BF6601532_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/(SICI)1097-0045(19970215)30:3<195::AID-PROS8>3.0.CO;2-L","volume":"30","author":"Y Arai","year":"1997","unstructured":"Arai Y, Yoshiki T, Yoshida O (1997) c-erbB-2 oncoprotein: a potential biomarker of advanced prostate cancer. Prostate 30: 195\u2013201","journal-title":"Prostate"},{"key":"BF6601532_CR3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0090-4295(97)00262-8","volume":"50","author":"E Corey","year":"1997","unstructured":"Corey E, Arfman EW, Oswin MM, Melchior SW, Tindall DJ, Young C Y-F, Ellis WJ, Vessella RL (1997) Detection of circulating prostatic cells by reverse transcriptase-polymerase chain reaction of human glandular kallikrein (hk2) and prostatic-specific antigen (PSA) messages. Urology 50: 184\u2013188","journal-title":"Urology"},{"issue":"3","key":"BF6601532_CR4","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/6495","volume":"5","author":"N Craft","year":"1999","unstructured":"Craft N, Shostak Y, Carey M, Sawyers C (1999) A mechanism for hormono-independent prostate cancer through modulation of androgen receptor signalling by the HER-2\/neu tyrosine kinase. Nat Med 5(3): 280\u2013285","journal-title":"Nat Med"},{"issue":"Suppl 4A","key":"BF6601532_CR5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0090-4295(00)00952-3","volume":"57","author":"AM De Marzo","year":"2001","unstructured":"De Marzo AM, Putzi MJ, Nelson WG (2001) New concepts in the pathology of prostatic epithelial carcinogenesis. Urology 57(Suppl 4A): 103\u2013114","journal-title":"Urology"},{"issue":"4","key":"BF6601532_CR6","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1023\/A:1014730829872","volume":"6","author":"SA Eccles","year":"2001","unstructured":"Eccles SA (2001) The role of c-erbB-2\/HER2\/neu in breast cancer progression and metastasis. J Mammary Gland Biol Neopl 6(4): 393\u2013406","journal-title":"J Mammary Gland Biol Neopl"},{"key":"BF6601532_CR7","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ijc.10286","volume":"99","author":"A Fossa","year":"2002","unstructured":"Fossa A, Lilleby W, Fossa SD, Gaudernack G, Torlakovic G, Berner A (2002) Independent prognostic significance of HER-2 oncoprotein expression in pNO prostate cancer undergoing curative radiotherapy. Int J Cancer 99: 100\u2013105","journal-title":"Int J Cancer"},{"key":"BF6601532_CR8","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1200\/JCO.1995.13.5.1195","volume":"13","author":"RA Ghossein","year":"1995","unstructured":"Ghossein RA, Scher HI, Gerald WL, Kelly WK, Curley T, Amsterdam A, Zhang Z-F, Rosai J (1995) Detection of circulating tumour cells in patients with localised and metastatic prostatic carcinoma: clinical implications. J Clin Oncol 13: 1195\u20131200","journal-title":"J Clin Oncol"},{"key":"BF6601532_CR9","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0304-3835(95)04061-7","volume":"99","author":"K Gu","year":"1996","unstructured":"Gu K, Mes-Masson AM, Gauthier J, Saad F (1996) Overexpression of her-2\/neu in human prostate cancer and benign hyperplasia. Cancer Lett 99: 185\u2013189","journal-title":"Cancer Lett"},{"issue":"6","key":"BF6601532_CR10","first-page":"1794","volume":"8","author":"N Hara","year":"2002","unstructured":"Hara N, Kasahara T, Kawasaki T, Bilim V, Obara K, Takahashi K, Tomita Y (2002) Reverse transcription-polymerase chain reaction detection of prostate-specific antigen, prostate-specific membrane antigen, and prostate stem cell antigen in one millilitre of peripheral blood. Clin Cancer Res 8(6): 1794\u20131799","journal-title":"Clin Cancer Res"},{"key":"BF6601532_CR11","first-page":"19","volume":"4","author":"NE Hynes","year":"1993","unstructured":"Hynes NE (1993) Amplification and overexpression of the erbB-2 gene in human tumours: its involvement in tumour development, significance as a prognostic factor, and potential as a target for cancer therapy. Semin Cancer Biol 4: 19\u201326","journal-title":"Semin Cancer Biol"},{"key":"BF6601532_CR12","first-page":"165","volume":"1198","author":"NE Hynes","year":"1994","unstructured":"Hynes NE, Stern DF (1994) The biology of erbB-2\/neu\/HER-2 and its role in cancer. Biochim Biophys Acta 1198: 165\u2013184","journal-title":"Biochim Biophys Acta"},{"key":"BF6601532_CR13","first-page":"6306","volume":"54","author":"RS Israeli","year":"1994","unstructured":"Israeli RS, Miller WH, Su SL, Powell CT, Fair WR, Samadi DS, Huryk RF, DeBlasio A, Edwards ET, Wise GJ, Heston WD (1994) Sensitive nested reverse transcription polymerase chain reaction detection of circulating prostatic tumor cells: comparison of prostatic-specific membrane antigen and prostate-specific antigen-based assays. Cancer Res 54: 6306\u20136310","journal-title":"Cancer Res"},{"key":"BF6601532_CR14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0090-4295(94)90132-5","volume":"43","author":"AE Katz","year":"1994","unstructured":"Katz AE, Olsson CA, Raffo AJ, Cama C, Perlman H, Seaman E, O'Toole KM, McMahon D, Benson MC, Buttyan R (1994) Molecular staging of prostate cancer with the use of an enhanced reverse-transcriptase-PCR assay. Urology 43: 765\u2013775","journal-title":"Urology"},{"issue":"10","key":"BF6601532_CR15","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1002\/cncr.10526","volume":"94","author":"PN Lara","year":"2002","unstructured":"Lara PN, Meyers FJ, Gray CR, Gandour Edwards R, Gumerlock PH, Kauderer C, Tichauer G, Twardowski P, Doroshow J, Gandara DR (2002) HER-2\/neu is overexpressed infrequently in patients with prostate carcinoma. Cancer 94(10): 2584\u20132589","journal-title":"Cancer"},{"issue":"1","key":"BF6601532_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000052414","volume":"39","author":"A Laribi","year":"2001","unstructured":"Laribi A, Berteau P, Gala J, Eschwege P, Benoit G, Tombal B, Schmitt F, Loric S (2001) Blood-borne RT-PCR assay for prostasin-specific transcripts to identify circulating prostate cells in cancer patients. Eur Urol 39(1): 65\u201371","journal-title":"Eur Urol"},{"key":"BF6601532_CR17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/jcp.43.3.213","volume":"43","author":"U Latza","year":"1990","unstructured":"Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H (1990) Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 43: 213\u2013219","journal-title":"J Clin Pathol"},{"key":"BF6601532_CR18","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1016\/S0022-5347(05)67621-5","volume":"163","author":"A Mejean","year":"2000","unstructured":"Mejean A, Vona G, Nalpas B, Damotte D, Brousse N, Chretien Y, Dufour B, Lacour B, Br\u00e9chot C, Paterlini-Br\u00e9chot P (2000) Detection of circulating prostate derived cells in patients with prostate adenocarcinoma is an independent risk factor for tumor recurrence. J Urol 163: 2022\u20132029","journal-title":"J Urol"},{"key":"BF6601532_CR19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/(SICI)1097-4652(200002)182:2<150::AID-JCP3>3.0.CO;2-E","volume":"182","author":"S Menard","year":"2000","unstructured":"Menard S, Tagliabue E, Campiglio M, Pupa SM (2000) Role of HER2 gene overexpression in breast carcinoma. J Cell Physiol 182: 150\u2013162","journal-title":"J Cell Physiol"},{"issue":"4","key":"BF6601532_CR20","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/cncr.10339","volume":"94","author":"MJ Morris","year":"2002","unstructured":"Morris MJ, Reuter VE, Kelly WK, Slovin SF, Kenneson K, Verbel D, Osman I, Scher HI (2002) HER-2 profiling and targeting in prostate carcinoma. A phase II trial of trastuzumab alone and with paclitaxel. Cancer 94(4): 980\u2013986","journal-title":"Cancer"},{"key":"BF6601532_CR21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S1368-8375(02)00029-5","volume":"38","author":"P O-charoenrat","year":"2002","unstructured":"O-charoenrat P, Rhys-Evans PH, Modjtahedi H, Eccles SA (2002) The role of c-erbB receptor and ligands in head and neck squamous cell carcinoma. Oral Oncology 38: 627\u2013640","journal-title":"Oral Oncology"},{"key":"BF6601532_CR22","first-page":"2643","volume":"7","author":"I Osman","year":"2001","unstructured":"Osman I, Scher HI, Drobnjak M, Verbel D, Morris M, Agus D, Ross JS, Cordon-Cardo C (2001) HER-2\/neu (p185neu) protein expression in the natural or treated history of prostate cancer. Clin Cancer Res 7: 2643\u20132647","journal-title":"Clin Cancer Res"},{"key":"BF6601532_CR23","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.onc.1201222","volume":"15","author":"MD Pergram","year":"1997","unstructured":"Pergram MD, Finn RS, Arzoo K, Beryt M, Pietras RJ, Slamon DJ (1997) The effect of HER-2\/neu overexpression on chemotherapeutic drug sensitivity in human breast and ovarian cancer calls. Oncogene 15: 537\u2013547","journal-title":"Oncogene"},{"issue":"11","key":"BF6601532_CR24","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2162::AID-CNCR14>3.0.CO;2-U","volume":"79","author":"JS Ross","year":"1997","unstructured":"Ross JS, Sheehan CE, Hayner-Buchan AM, Ambros RA, Kallakury BVS, Kaufman RP, Fisher HAG, Rifkin MD, Muraca PJ (1997) Prognostic significance of HER-2\/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma. Cancer 79(11): 2162\u20132170","journal-title":"Cancer"},{"key":"BF6601532_CR25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0022-5347(17)35413-7","volume":"150","author":"R Sadasivan","year":"1993","unstructured":"Sadasivan R, Morgan R, Jennings S, Austenfeld M, Van Veldhuizen P, Stephens R, Noble M (1993) Overexpression of HER-2\/neu may be an indicator of poor prognosis in prostate cancer. J Urol 150: 126\u2013131","journal-title":"J Urol"},{"key":"BF6601532_CR26","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1126\/science.2992090","volume":"229","author":"AL Schechter","year":"1985","unstructured":"Schechter AL, Hung MC, Vaidyanathan L, Weinberg RA, Yang-Feng TL, Francke U, Ullrich A, Coussens L (1985) The neu gene: an erbB-homologous gene distinct from and unlinked to the gene encoding the EGF receptor. Science 229: 976\u2013978","journal-title":"Science"},{"key":"BF6601532_CR27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0090-4295(99)00471-9","volume":"55","author":"HI Scher","year":"2000","unstructured":"Scher HI, Heller G (2000) Clinical states in prostate cancer: toward a dynamic model of disease progression. Urology 55: 323\u2013327","journal-title":"Urology"},{"key":"BF6601532_CR28","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1200\/JCO.1994.12.12.2634","volume":"12","author":"MV Seiden","year":"1995","unstructured":"Seiden MV, Kantoff PW, Krithivas K, Propert K, Bryant M, Haltom E, Gaynes L, Kaplan I, Bubley G, DeWolf W, Sklar J (1995) Detection of circulating tumor cells in men with localized prostate cancer. J Clin Oncol 12: 2634\u20132639","journal-title":"J Clin Oncol"},{"issue":"23","key":"BF6601532_CR29","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/jnci\/92.23.1918","volume":"92","author":"S Signoretti","year":"2000","unstructured":"Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, Balk S, Thomas G, Kaplan I, Hlatky L, Hahnfeldt P, Kantoff P, Loda M (2000) Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst 92(23): 1918\u20131925","journal-title":"J Natl Cancer Inst"},{"key":"BF6601532_CR30","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1056\/NEJM200103153441101","volume":"344","author":"D Slamon","year":"2001","unstructured":"Slamon D, Leyland-Jones B, Shak S, Fuchs H, Paton V, Bajamonde A, Fleming T, Eiermann W, Wolter J, Pegram M, Baselga J, Norton L (2001) Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpressed HER2. N Engl J Med 344: 783\u2013792","journal-title":"N Engl J Med"},{"key":"BF6601532_CR31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","volume":"235","author":"DJ Slamon","year":"1987","unstructured":"Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL (1987) Human breast cancer: correlation of relapse and survival with amplification of the Her-2\/neu oncogene. Science 235: 177\u2013182","journal-title":"Science"},{"issue":"15","key":"BF6601532_CR32","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0093-7754(01)90159-9","volume":"4","author":"EJ Small","year":"2001","unstructured":"Small EJ, Bok R, Reese DM, Sudilovsky D, Frohlich M (2001) Docetaxel, estramustine, plus trastuzumab in patients with metastatic androgen-independent prostate cancer. Sem Oncol 4(15): 71\u201376","journal-title":"Sem Oncol"},{"key":"BF6601532_CR33","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/S0022-5347(01)65447-8","volume":"156","author":"MH Sokoloff","year":"1996","unstructured":"Sokoloff MH, Tso CL, Kaboo R, Nelson S, Ko J, Dorey F, Figlin RA, Pang S, DeKernion J, Belldegrun A (1996) Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients. J Urol 156: 1560\u20131566","journal-title":"J Urol"},{"key":"BF6601532_CR34","first-page":"971","volume":"5","author":"JC Soria","year":"1999","unstructured":"Soria JC, Gauthier LR, Raymond E, Granotier C, Morat L, Armand J-P, Boussin FD, Sabatier L (1999) Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients. Clin Cancer Res 5: 971\u2013975","journal-title":"Clin Cancer Res"},{"key":"BF6601532_CR35","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1200\/JCO.1997.15.12.3451","volume":"15","author":"DP Wood","year":"1997","unstructured":"Wood DP, Banerjee M (1997) Presence of circulating prostate cells in the bone marrow of patients undergoing radical prostatectomy is predictive of disease free survival. J Clin Oncol 15: 3451\u20133457","journal-title":"J Clin Oncol"},{"key":"BF6601532_CR36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/319230a0","volume":"319","author":"T Yamamoto","year":"1986","unstructured":"Yamamoto T, Ikawa S, Akiyama T, Semba K, Nomura N, Miyajima N, Saito T, Toyoshima K (1986) Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor. Nature 319: 230\u2013234","journal-title":"Nature"},{"key":"BF6601532_CR37","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1200\/JCO.2001.19.8.2334","volume":"19","author":"H Yamauchi","year":"2001","unstructured":"Yamauchi H, Stearns V, Hayes DF (2001) When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer. J Clin Oncol 19: 2334\u20132356","journal-title":"J Clin Oncol"},{"key":"BF6601532_CR38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/(SICI)1097-0045(199602)28:2<73::AID-PROS1>3.0.CO;2-O","volume":"28","author":"HYE Zhau","year":"1999","unstructured":"Zhau HYE, Zhou J, Fraser Symmans WF, Chen B-Q, Chang S-M, Sikes RA, Chung LWK (1999) Transfected neu oncogene induces human prostate cancer metastasis. Prostate 28: 73\u201383","journal-title":"Prostate"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6601532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601532","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6601532.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:55:16Z","timestamp":1684414516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6601532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["BF6601532"],"URL":"https:\/\/doi.org\/10.1038\/sj.bjc.6601532","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}